Le Turnier P, Charreau I, Gabassi A, Carette D, Cotte L,
Pialoux G, Tremblay C, Spire B, Chaix Baudier ML, Meyer L, Capitant C,
Delaugerre C, Raffi F, Molina JM, for the ANRS IPERGAY study group. Hepatitis A and B Vaccine Uptake And Immunisation Among Men Who Have
Sex With Men Seeking PrEP: A Substudy Of The ANRS IPERGAY Trial.
Sexually Transmitted Infections 2022 Dec 8. Lien PubMed
Ciesielski TH, Zhang X, Tacconelli A, Lutsar I, de Cabre VM,
Roilides E, Ciccacci C, Borgiani P, Scott WK; NeoMero Consortium,
Williams SM, Sirugo G.
Late-onset neonatal sepsis: genetic differences by sex and involvement of the NOTCH pathway. Pediatr Res 2022 Jul 14. Lien PubMed
Chéret A, Bauer R, Meiffrédy V, Lopez P, Ajana F, Lacombe K,
Morlat P, Lascoux C, Reynes J, Calin R, Abel S, Goujard C, Rouzioux C,
Avettand-Fenoel V, Meyer L.
Once-daily dolutegravir versus
darunavir plus cobicistat in adults at the time of primary HIV-1
infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial.
J
Antimicrob Chemother
2022 Jun 28 Lien PubMed
Segeral O, Dim B, Durier C, Nhoueng S, Chhim K, Sovann S, Yom
S, Vong C, Yin S, Ros B, Ky V, Pech S, Nem B, Hout K, Guillebaud J, Ear
E, Caroupaye-Caroupin L, Rekacewicz C, Fernandez L, Laurent D, Yay C,
Kim R, Meyer L, Chhun S, Borand L for the ANRS 12345 TA PROHM Study
Group.
Immunoglobulin-free strategy to prevent HBV
mother-to-child transmission in Cambodia: the ANRS 12345 TA-PROHM
single-arm trial. Lancet Inf Dis 2022. 2022 May 25 Lien PubMed
Molino D, Durier C, Radenne A, Desaint C, Ropers J, Courcier
S, Vieillard LV, Rekacewicz C, Parfait B, Appay V, Batteux F, Barillot
E, Cogné M, Combadière B, Eberhardt CS, Gorochov G, Hupé P, Ninove L,
Paul S, Pellegrin I, van der Werf S, Lefebvre M, Botelho-Nevers E,
Ortega-Perez I, Jaspard M, Sow S, Lelièvre JD, de Lamballerie X, Kieny
MP, Tartour E, Launay O.
A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project. Nat Med. 2022 May 5 Lien PubMed
Luong Nguyen LB, Bauer R, Lesieur Z, Galtier F, Duval X, Vanhems P, Lainé F, Tattevin P, Durier C, Launay O. FLUVAC Study group.
Vaccine effectiveness against COVID-19 hospitalization in adults in
France: A test negative case control study. Infect Dis Now. 2022 Feb Lien PubMed
Mariaggi A-A, Bauer R, Charre C, Gardiennet E, Meiffredy V, Ajana F, Lacombe K, Pialoux G, Cua E, Rouzioux C, Meyer L, Chéret A; Avettand-Fenoel V. HIV-1
RNA and total HIV-1 DNA loads in genital compartment in men receiving
Dolutegravir- versus Darunavir-based cART regimens during the primary
HIV infection. Journal of Antimicrobial Chemotherapy. 2022 Fev 23 Lien PubMed
Zeggagh J, Bauer R, Delaugerre C, Carette D, Fressard L,
Charreau I, Chidiac C, Pialoux G, Tremblay C, Cua E, Robineau O, Raffi
F, Capitant C, Spire B, Meyer L, Molina JM and the Ipergay study group. Incidence
and risk factors for recurrent sexually transmitted infections among
men who have sex with men on HIV pre-exposure prophylaxis. AIDS 2022 Feb
9 Lien PubMed
Durier C, Mercier-Delarue S, Verdière NC, Meiffrédy V,
Matheron S, Samri A, Resch M, Marchand L, Autran B, Launay O, Simon F; ANRS NOVAA EP46 study group. A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults. AIDS. 2022 Feb 1. Lien PubMed
Launay O, Artaud C, Lachâtre M, Ait-Ahmed M, Klein J, Luong
Nguyen LB, Durier C, Jansen B, Tomberger Y, Jolly N, Grossmann A, Tabbal
H, Brunet J, Gransagne M, Choucha Z, Batalie D, Delgado A, Müllner M,
Tschismarov R, Berghmans PJ, Martin A, Ramsauer K, Escriou N, Gerke C. Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine
candidate, V591 / TMV-083, in healthy adults: results of a randomized,
placebo-controlled Phase I study. EBioMedicine. 2022 Jan 16 Lien PubMed